INTROMEDICAL_LIMITED - Accounts


Company Registration No. 05092871 (England and Wales)
INTROMEDICAL LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2017
PAGES FOR FILING WITH REGISTRAR
INTROMEDICAL LIMITED
COMPANY INFORMATION
Director
Dr PJ Gandy
Company number
05092871
Registered office
Linney's Cottage
Northweirs
Brockenhurst
SO42 7QA
Accountants
Verve Accounting Limited
198 Shirley Road
Southampton
UK
SO15 3FL
Business address
Linney's Cottage
Northweirs
Brockenhurst
SO42 7QA
INTROMEDICAL LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Statement of changes in equity
3
Notes to the financial statements
4 - 7
INTROMEDICAL LIMITED
BALANCE SHEET
AS AT
30 APRIL 2017
30 April 2017
1
2017
2016
Notes
£
£
£
£
Fixed assets
Tangible assets
3
-
6,036
Current assets
Debtors
4
39,272
52,454
Cash at bank and in hand
-
6,772
39,272
59,226
Creditors: amounts falling due within one year
5
(24,719)
(64,338)
Net current assets/(liabilities)
14,553
(5,112)
Total assets less current liabilities
14,553
924
Creditors: amounts falling due after more than one year
6
(7,917)
-
Net assets
6,636
924
Capital and reserves
Called up share capital
7
2
2
Profit and loss reserves
6,634
922
Total equity
6,636
924

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 30 April 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.

INTROMEDICAL LIMITED
BALANCE SHEET (CONTINUED)
AS AT
30 APRIL 2017
30 April 2017
2
The financial statements were approved and signed by the director and authorised for issue on 31 January 2018
Dr PJ Gandy
Director
Company Registration No. 05092871
INTROMEDICAL LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 30 APRIL 2017
3
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 May 2015
2
587
589
Year ended 30 April 2016:
Profit and total comprehensive income for the year
-
22,335
22,335
Dividends
-
(22,000)
(22,000)
Balance at 30 April 2016
2
922
924
Year ended 30 April 2017:
Profit and total comprehensive income for the year
-
25,712
25,712
Dividends
-
(20,000)
(20,000)
Balance at 30 April 2017
2
6,634
6,636
INTROMEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2017
4
1
Accounting policies
Company information

Intromedical Limited is a private company limited by shares incorporated in England and Wales. The registered office is Linney's Cottage, Northweirs, Brockenhurst, SO42 7QA.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

These financial statements for the year ended 30 April 2017 are the first financial statements of Intromedical Limited prepared in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland. The date of transition to FRS 102 was 1 May 2015. The reported financial position and financial performance for the previous period are not affected by the transition to FRS 102.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures, fittings & equipment
25% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

INTROMEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2017
1
Accounting policies (Continued)
5
1.4
Cash at bank and in hand

Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.6
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

2
Taxation
2017
2016
£
£
Current tax
UK corporation tax on profits for the current period
7,896
7,093
INTROMEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2017
6
3
Tangible fixed assets
Fixtures, fittings & equipment
£
Cost
At 1 May 2016 and 30 April 2017
46,209
Depreciation and impairment
At 1 May 2016
40,173
Depreciation charged in the year
6,036
At 30 April 2017
46,209
Carrying amount
At 30 April 2017
-
At 30 April 2016
6,036
4
Debtors
2017
2016
Amounts falling due within one year:
£
£
Other debtors
39,272
52,454
5
Creditors: amounts falling due within one year
2017
2016
£
£
Bank loans and overdrafts
9,664
-
Corporation tax
15,055
14,338
Other creditors
-
50,000
24,719
64,338
6
Creditors: amounts falling due after more than one year
2017
2016
£
£
Bank loans and overdrafts
7,917
-
INTROMEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2017
7
7
Called up share capital
2017
2016
£
£
Ordinary share capital
Issued and fully paid
2 Ordinary of £1 each
2
2
2
2
8
Controlling party

The ultimate controlling party is the director P Gandy, by virtue of his shareholdings.

9
Employees

The average monthly number of persons (including directors) employed by the company during the year was 2 (2016 - 2).

2017-04-302016-05-01falseCCH SoftwareCCH Accounts Production 2017.400No description of principal activity31 January 2018050928712016-05-012017-04-3005092871bus:Director12016-05-012017-04-3005092871bus:RegisteredOffice2016-05-012017-04-30050928712017-04-30050928712016-04-3005092871core:FurnitureFittings2016-04-3005092871core:CurrentFinancialInstruments2017-04-3005092871core:CurrentFinancialInstruments2016-04-3005092871core:Non-currentFinancialInstruments2017-04-3005092871core:ShareCapital2017-04-3005092871core:ShareCapital2016-04-3005092871core:ShareCapitalcore:RestatedAmount2015-04-3005092871core:RestatedAmount2015-04-3005092871core:ShareCapitalOrdinaryShares2017-04-3005092871core:ShareCapitalOrdinaryShares2016-04-30050928712015-05-012016-04-3005092871core:RetainedEarningsAccumulatedLosses2015-05-012016-04-3005092871core:FurnitureFittings2016-05-012017-04-3005092871core:UKTax2016-05-012017-04-3005092871core:UKTax2015-05-012016-04-3005092871core:FurnitureFittings2016-04-3005092871core:FurnitureFittings2017-04-3005092871bus:OrdinaryShareClass12016-05-012017-04-3005092871bus:OrdinaryShareClass12017-04-3005092871bus:PrivateLimitedCompanyLtd2016-05-012017-04-3005092871bus:FRS1022016-05-012017-04-3005092871bus:AuditExemptWithAccountantsReport2016-05-012017-04-3005092871bus:SmallCompaniesRegimeForAccounts2016-05-012017-04-3005092871bus:FullAccounts2016-05-012017-04-30xbrli:purexbrli:sharesiso4217:GBP